SURUNKALI GEPATITLAR: DIAGNOSTIKA, DAVOLASH VA PROFILAKTIKA
Main Article Content
Abstract:
Surunkali gepatit jigar to‘qimasining olti oy va undan ko‘p davom etadigan doimiy yallig‘lanishi bilan tavsiflangan progresiv kasallikdir. U turli virusli infeksiyalar, autoimmun kasalliklar, metabolik buzilishlar yoki jigar to‘qimasiga zarar yetkazuvchi moddalar bilan uzoq muddatli ta’sir natijasida yuzaga kelishi mumkin. Surunkali gepatit ko‘pincha dastlab belgilanmaydi, bu esa erta tashxisni qiyinlashtiradi. Davolanmasa, kasallik jigar fibroziga, sirrozga yoki gepatosellyulyar karsinomaga o‘tishi mumkin, bu esa dunyo bo‘yicha bemorlik va o‘lim ko‘rsatkichlariga sezilarli ta’sir ko‘rsatadi. Ushbu maqola kasallikni aniqlash usullari, jumladan serologik testlar, jigar funktsional testlari, tasvirlash texnologiyalari va jigar biopsiyasini ko‘rib chiqadi, bu esa kasallik bosqichini aniqlash va davolash strategiyasini belgilashga yordam beradi. Davolash gepatit turiga va kasallik og‘irligiga qarab farqlanadi: antiviral terapiya, immunomodulyator vositalar, hayot tarzi o‘zgarishlari va asoratlarni boshqarish muhim o‘rin tutadi. Profilaktik chora-tadbirlar, jumladan emlash, xavfsiz in’ektsiya amaliyotlari va jamoatchilik salomatligi dasturlari, kasallik yuzaga kelishini va yukini kamaytirishda muhimdir. Erta tashxis, individual davolash va keng qamrovli profilaktika surunkali gepatitda klinik natijalarni yaxshilash va bemorlarning hayot sifatini oshirish uchun zarurdir.
Article Details
How to Cite:
References:
World Health Organization. Global Hepatitis Report 2021. Geneva: WHO; 2021.
Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599.
European Association for the Study of the Liver (EASL). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–398.
Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med. 2013;368:1907–1917.
Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–2213.
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.
